Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
82.80
-9.79 (-10.57%)
At close: Apr 28, 2026, 4:00 PM EDT
82.96
+0.16 (0.19%)
After-hours: Apr 28, 2026, 4:46 PM EDT
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $2.09B in the quarter ending March 31, 2026, with 9.30% growth. This brings the company's revenue in the last twelve months to $8.41B, up 9.23% year-over-year. In the year 2025, Zimmer Biomet Holdings had annual revenue of $8.23B with 7.20% growth.
Revenue (ttm)
$8.41B
Revenue Growth
+9.23%
P/S Ratio
1.91
Revenue / Employee
$494,653
Employees
17,000
Market Cap
16.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.23B | 552.90M | 7.20% |
| Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
| Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
| Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
| Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.94B |
| GE HealthCare Technologies | 20.63B |
| Smith & Nephew | 6.16B |
| STERIS | 5.83B |
| DexCom | 4.66B |
| Globus Medical | 2.94B |
| Insulet | 2.71B |
| Bio-Rad Laboratories | 2.58B |
ZBH News
- 1 hour ago - Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday? - Benzinga
- 8 hours ago - Zimmer Biomet Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 8 hours ago - Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure - Reuters
- 10 hours ago - Zimmer Biomet Announces First Quarter 2026 Financial Results - PRNewsWire
- 10 hours ago - Zimmer Biomet Announces Chief Financial Officer Transition - PRNewsWire
- 19 days ago - Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results - PRNewsWire
- 21 days ago - Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer - PRNewsWire
- 7 weeks ago - Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire